AMAG Pharmaceuticals (AMAG)
Your Dashboard
Displaying AMAG Charts
Personalize your Dashboard. You can add and remove charts, drag and drop them into the order you
like, and we'll save your settings for the next time you visit when you're logged in.
Log in here or Click here to register for your free account.
Select or add more charts
- Accounts Payable 3.398M
- Accounts Receivable 6.648M
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization 0.2283
- Beneish M-Score Pro
- Beta Pro
- Book Value 169.92M
- Book Value per Share 8.015
- Capital Expenditures 0.047M
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing 0.00
- Cash Financing TTM 0.619M
- Cash Investing -14.75M
- Cash Investing TTM 13.37M
- Cash Operations -11.11M
- Cash Operations TTM -53.69M
- Cash and Equivalents 37.62M
- Cash and ST Investments 200.45M
- Current Ratio 6.019
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio 0.00
- Dividend
- Dividend Yield 0.00%
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share -0.58
- Earnings Per Share Growth
- Earnings Per Share TTM -3.17
- Earnings Yield -22.81%
- Effective Tax Rate TTM Pro
- Enterprise Value 257.06M
- Expenses 27.90M
- Expenses TTM 130.53M
- Free Cash Flow -11.15M
- Free Cash Flow TTM -54.16M
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin 82.91%
- Gross Profit TTM 53.21M
- Income from Cont. Ops Pro
- Interest Expense 0.00
- Interest Income 0.393M
- Inventories 14.26M
- KZ Index Pro
- Liabilities 83.74M
- Long Term Debt 0.00
- Market Cap 294.68M
- Net Income -12.42M
- Net Income TTM -67.19M
- Net PP&E 8.702M
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price 13.90
- Price / Book Value 1.734
- Price / Sales Ratio 4.652
- Price / Tangible Book Value Pro
- Profit Margin -80.21%
- R&D Expense 12.46M
- Receivables Turnover 9.507
- Retained Earnings -452.32M
- Retained Earnings Growth
- Return on Assets -23.57%
- Return on Equity -34.05%
- Return on Invested Capital Pro
- Revenue Growth 15.65%
- Revenue Per Share TTM 2.988
- Revenues 15.48M
- Revenues TTM 63.34M
- SG&A Expense 13.18M
- Shareholders Equity 169.92M
- Shares Outstanding 21.20M
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets 253.67M
- Total Return Price 13.90
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
What do these terms mean? Read all about them in the Glossary.
You may also be interested in these AMAG related companies
AMAG News
AMAG (AMAG) Shares Collapse as Board Quietly Abandons Active Sale Process
May 10, 12:41PM Street Insider
May 10, 12:41PM Street Insider
Correction - Landenburg Thalmann Downgraded AMAG Pharmaceuticals (AMAG) to Hold
May 10, 8:41AM Street Insider
May 10, 8:41AM Street Insider
Baird Downgrades AMAG Pharmaceuticals (AMAG) to Neutral; Stepping To Sidelines As Risk Profile Increases
May 10, 8:06AM Street Insider
May 10, 8:06AM Street Insider
AMAG Pharmaceuticals Appoints William Heiden as President and Chief Executive Officer
May 09, 4:09PM Benzinga
May 09, 4:09PM Benzinga
Listen to $AMAG Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3bwJ
about 26 days ago by earningscast
about 26 days ago by earningscast
AMAG Pharma (AMAG) Pops Higher on Positive CHMP Opinion for Ferumoxytol
Apr 20, 9:36AM Street Insider
Apr 20, 9:36AM Street Insider
AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europ
Apr 20, 9:33AM Benzinga
Apr 20, 9:33AM Benzinga
$AMAG forms bearish "Continuation Diamond" chart pattern. http://stks.co/3209
about 65 days ago by RecogniaEvents
about 65 days ago by RecogniaEvents
Baird Reiterates an 'Outperform' on AMAG Pharmaceuticals (AMAG); Positive IDA Trial De-Risks Major Opportunity
Mar 08, 10:02AM Street Insider
Mar 08, 10:02AM Street Insider
Listen to $AMAG Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2gGF
about 83 days ago by earningscast
about 83 days ago by earningscast
$AMAG Q4 2011 Earnings Conference Call Mar.5th at 4:30 p.m. ET. Webcast @ http://stks.co/2f03
about 85 days ago by abubnic
about 85 days ago by abubnic
$AMAG Ceo will participate at the 24th Annual ROTH Conference on Mar 13 at 4:30 pm PT. Webcast @ http://stks.co/2f00
about 85 days ago by abubnic
about 85 days ago by abubnic
$AMAG Downside Blowoff - 15 Minute Up Reversal - Green bar after 5 red bars
about 139 days ago by TradeIdeasQuant
about 139 days ago by TradeIdeasQuant
$AMAG "No serious adverse events were reported" in results of test on company's ferumoxytol
about 167 days ago by Benzinga
about 167 days ago by Benzinga
If you were patient enough to hold onto $amag through the summer/fall you are up pretty nicely
about 172 days ago by DavidSchawel
about 172 days ago by DavidSchawel
$AMAG 200 Day SMA Cross - Price crossed below 200 day SMA (16.1075). Confirmed by volume.
about 192 days ago by TradeIdeasQuant
about 192 days ago by TradeIdeasQuant
AMAG Pharmaceuticals $AMAG up 4% after hiring Jefferies to explore options, including a potential sale.
about 192 days ago by Street_Insider
about 192 days ago by Street_Insider
15 breakouts: $AMAG (200-day MA + gap + base), $MXWL (stop: $17.99), $MDAS (gap). Two sub-$1. Okay mix of stocks if some are extended.
about 203 days ago by fallondpicks
about 203 days ago by fallondpicks
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AMAG | 13.90 | +0.35 | +2.58% | 294.68M |
| AM | 14.27 | -0.10 | -0.70% | 546.83M |
| ALXN | 92.42 | -0.68 | -0.73% | 17.19B |
| ALX | 391.06 | +0.06 | +0.02% | 1.998B |
| ALVR | 0.49 | +0.03 | +6.52% | 28.41M |
| AMNB | 22.00 | -0.24 | -1.08% | 172.26M |
| AMLP | 15.95 | +0.05 | +0.31% | |
| AMLN | 27.96 | +2.16 | +8.37% | 4.496B |
| AMKR | 4.65 | +0.07 | +1.53% | 782.83M |
| AMJ | 37.36 | +0.23 | +0.62% |